<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2077-8333/epi.par.con.2025.231</article-id><article-id custom-type="elpub" pub-id-type="custom">epilepsia-1239</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC SURVEYS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>Bioelectronic medicine: a new frontier for autonomic nervous system disorders</article-title><trans-title-group xml:lang="ru"><trans-title>Биоэлектронная медицина: новый рубеж в лечении заболеваний вегетативной нервной системы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7655-1667</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дхалл</surname><given-names>М.</given-names></name><name name-style="western" xml:lang="en"><surname>Dhall</surname><given-names>M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маниш Дхалл, магистр фармацевтики, доктор философии</p><p>Дарьяо Нагар, Рохтак, Харьяна 124001</p></bio><bio xml:lang="en"><p>Manish Dhall, M. Pharm., PhD</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-4117-2940</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тушир</surname><given-names>Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Tushir</surname><given-names>R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рену Тушир, магистр фармацевтики</p><p>Сохна, Гуруграм, Харьяна 122103</p></bio><bio xml:lang="en"><p>Renu Tushir, M. Pharm.</p></bio><email xlink:type="simple">renutushir8@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9539-3139</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шарма</surname><given-names>П.</given-names></name><name name-style="western" xml:lang="en"><surname>Sharma</surname><given-names>P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Прерна Шарма, доцент</p><p>XV69+CQH, Амри-роуд, сектор 8, Курукшетра, Харьяна 136118</p></bio><bio xml:lang="en"><p>Prerna Sharma, Assoc. Prof.</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2549-3481</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рани</surname><given-names>Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rani</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нидхи Рани, магистр фармацевтики, доктор философии, доцент</p><p>Пенджаб 140401</p></bio><bio xml:lang="en"><p>Nidhi Rani, M. Pharm., PhD, Assoc. Prof</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2979-1590</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сингх</surname><given-names>Т. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Singh</surname><given-names>T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тхакур Гуржит Сингх, проф.</p><p>WoS ResearcherID: AGV-7671-2022</p><p>Scopus Author ID: 27667828700 </p><p>Пенджаб 140401</p></bio><bio xml:lang="en"><p>Thakur Gurjeet Singh, Prof.</p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Университет медицинских наук Пандита Бхагвата Даяла Шармы</institution><country>Индия</country></aff><aff xml:lang="en"><institution>College of Pharmacy, PGIMS (SDPGIPS) Pandit Bhagwat Dayal Sharma University of Health Sciences ROHTAK-124001</institution><country>India</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Университет Г.Д. Гоенка</institution><country>Индия</country></aff><aff xml:lang="en"><institution>GD Goneka University</institution><country>India</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Университет Шри Кришны АЮШ</institution><country>Индия</country></aff><aff xml:lang="en"><institution>Shri Kirishna AYUSH University</institution><country>India</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Университет Читкара</institution><country>Индия</country></aff><aff xml:lang="en"><institution>Chitkara College of Pharmacy, Сhitkara University</institution><country>India</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>14</day><month>10</month><year>2025</year></pub-date><volume>17</volume><issue>3</issue><fpage>297</fpage><lpage>307</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Dhall M., Tushir R., Sharma P., Rani N., Singh T.Г., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Дхалл М., Тушир Р., Шарма П., Рани Н., Сингх Т.Г.</copyright-holder><copyright-holder xml:lang="en">Dhall M., Tushir R., Sharma P., Rani N., Singh T.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/1239">https://www.epilepsia.su/jour/article/view/1239</self-uri><abstract><p>Bioelectronic medicine is a field of study that is constantly evolving as a result of recent advancements and improvements in bioelectronic technology, which have led to novel approaches and perspectives in disease diagnosis and therapy, particularly in the inflammatory reflex immuno-regulatory functioning and, vagus nerve stimulation (VNS). The vagus nerve, an elongated nerve in the autonomic nervous system, controls a number of physiological processes in humans, including blood pressure, breathing rate, vasomotor activity, and certain reflex movements. Recent bioelectronic research has led to clinical tests using VNS for inflammatory diseases and other conditions. By sending steady, gentle electric impulses through the vagus nerve to the brain, bioelectronic devices can activate the vagus nerve. The integration of artificial intelligence (AI) with bioelectronic medicine is transforming drug development processes. AI technology can accelerate or even eliminate many time-consuming tasks, allowing healthcare professionals to use their time more efficiently and ultimately improving healthcare outcomes. This review discusses the vagus nerve’s roles in inflammation, stimulation, and regulation in animal models, as well as its therapeutic potential in treating human inflammation. Additionally, it examines how AI-powered bioelectronic drugs are being explored for conditions such as paralysis and immune disorders, and addresses the challenges of delivering large molecules using these drugs. The article emphasizes current trends, advancements, and the promising future applications of combining AI with bioelectronic medicine.</p></abstract><trans-abstract xml:lang="ru"><p>Биоэлектронная медицина – это область исследований, которая постоянно развивается благодаря последним достижениям и совершенствованию биоэлектронных технологий, которые привели к появлению новых подходов и перспектив в диагностике и терапии заболеваний, в частности в области воспалительных рефлекторных иммунорегуляторных  функций и стимуляции блуждающего нерва (англ. vagus nerve stimulation, VNS). Блуждающий нерв, протяженный нерв вегетативной нервной системы, контролирует ряд физиологических  процессов в организме человека, включая артериальное давление, частоту дыхания, вазомоторную активность и некоторые рефлекторные движения. Недавние исследования в сфере биоэлектроники позволили проводить клинические тесты с использованием технологии VNS при воспалительных заболеваниях и других состояниях. Посылая непрерывные слабые электрические импульсы через блуждающий нерв в мозг, биоэлектронные устройства могут активировать блуждающий нерв. Интеграция искусственного интеллекта (ИИ) с биоэлектронной медициной преобразует процессы разработки лекарственных препаратов. Технологии ИИ могут ускорить или даже исключить выполнение различных трудоемких задач, позволяя медицинским работникам более эффективно использовать свое время и, в конечном итоге, улучшать результаты лечения. В настоящем обзоре рассмотрена роль блуждающего нерва в воспалении, стимуляции и регуляции в животных моделях, его терапевтический потенциал в лечении воспаления у человека. Кроме того, освещены вопросы проведения исследований по оценке биоэлектронных препаратов на основе ИИ для терапии таких состояний, как паралич и иммунные расстройства, а также доставки крупных молекул с помощью указанных препаратов. Проанализированы текущие тенденции, достижения и перспективные подходы к применению ИИ в биоэлектронной медицине.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>иммунорегуляторные механизмы</kwd><kwd>рефлекторная активность</kwd><kwd>биоэлектронные препараты</kwd><kwd>ревматоидный артрит</kwd><kwd>искусственный интеллект</kwd><kwd>стимуляция блуждающего нерва</kwd></kwd-group><kwd-group xml:lang="en"><kwd>immuno-regulatory mechanisms</kwd><kwd>reflex activities</kwd><kwd>bioelectronic medicines</kwd><kwd>rheumatoid arthritis</kwd><kwd>artificial intelligence</kwd><kwd>vagus nerve stimulation</kwd></kwd-group></article-meta></front><body><sec><title>INTRODUCTION / ВВЕДЕНИЕ</title><p>Steady electrical and compound signaling cells, organs, and organisms to keep up with homeostasis, which empowers different physiological outcomes to respond to the cut and contamination. Analytical treatments that synergize or affect these natural signs are expected to ease or completely resolve a clinical infirmity [<xref ref-type="bibr" rid="cit1">1</xref>]. These days, medicines are essentially connected with compound signs, with the medications oftentimes focusing on cell receptors, chemicals, proteins, or DNA [<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>The role of electrical signals has been successfully reported in novel ways for distinct APIs' functions and to introduce an elective idea into restorative direct. In 1762, Galvani, an Italian doctor, presented the expression "bioelectricity", where he discussed how nerves and muscles communicate by sending electrical impulses through the neural system [<xref ref-type="bibr" rid="cit3">3</xref>]. Electrical stimulation and electrophysiological recording are two methods of two-way communication with the nervous system. The first electroencephalogram, which assessed how muscles responded to an electrical cortical input and enabled the identification of somatosensory evoked potentials, led to the development of modern somatosensory maps. The motor cortex's topography has also been studied in order to quantify this reaction [<xref ref-type="bibr" rid="cit4">4</xref>][<xref ref-type="bibr" rid="cit5">5</xref>]. Cellular research has been done on the electrical properties of nerve cells. It has been discovered that nerve cells contain a sort of electrical energy known as membrane potential. A specific type of neuronal discharge pattern is an action potential [<xref ref-type="bibr" rid="cit6">6</xref>][<xref ref-type="bibr" rid="cit7">7</xref>]. Dysregulated immunological reactions that result in persistent inflammation are a distinctive component of the aetiology of rheumatoid arthritis [<xref ref-type="bibr" rid="cit8">8</xref>].</p><p>When it comes to responding to aberrant inflammation, which is crucially important in the pathophysiology of many diseases, the use of electricity stimulates a great interest in researching the stimulation of vagus nerves and other procedures based on the inflammatory results [<xref ref-type="bibr" rid="cit9">9</xref>][<xref ref-type="bibr" rid="cit10">10</xref>]. In certainty, nerves not only transport essential sensory data but also messages to and from our brain, virtually every bodily module, and our organs. If the information is being communicated by electrical impulses from the nerves, it could be possible to intercept those signals and use modern sensing techniques and technology to decipher or interpret their meaning in order to extract the necessary data. The capacity to catch and decode neural impulses inside the central nervous system (CNS) has been exhibited now [<xref ref-type="bibr" rid="cit11">11</xref>]. It has been confirmed that even in a immobilized individuals’ years after their disease, these methods can be used to infer signals in the motor region. In reality, it has been shown that paralyzed patient might control a PC cursor by just envisioning the movements of their incapacitated appendage. The developments of appendages in a immobilized patient can be re-established by decoding their decisions and once again connecting with their muscles, as expressed by the first-in-human review [<xref ref-type="bibr" rid="cit12">12</xref>][<xref ref-type="bibr" rid="cit13">13</xref>].</p><p>These days, neurostimulation is used to treat conditions, for example, chronic Parkinson's disease, breathing problems, gut health and sexual dysfunctions, epilepsy, Alzheimer's disease and hypertension, impulsive issues. Crohn's sickness and rrheumatoid joint pain have both been effectively treated with bioelectronic treatment already. The development of tumour necrosis factor (TNF) in the liver and the beginning of shock was repressed in rodents during endotoxemia by the excitement of the fringe vagus nerve and furthermore the tweak of aggravation and the reaction to endotoxin could be seen because of efferent vagus nerve flagging [<xref ref-type="bibr" rid="cit14">14</xref>][<xref ref-type="bibr" rid="cit15">15</xref>].</p></sec><sec><title>VAGUS NERVE FUNCTIONING / ФУНКЦИИ БЛУЖДАЮЩЕГО НЕРВА</title><p>The vagus nerve is a combination of both afferent and efferent neurons. The function of efferent neurons in the vagus nerve started in the dorsal motor nucleus (DMN) and ambiguous nucleus (NA) in the brainstem medulla oblongata, is to build up a few instinctive organs [<xref ref-type="bibr" rid="cit16">16</xref>]. These long pre-ganglionic neurons, interconnected with post-ganglionic neurons is available in close contact or inside the innervated structures [<xref ref-type="bibr" rid="cit17">17</xref>][<xref ref-type="bibr" rid="cit18">18</xref>].</p><p>The significant function of the vagus nerve is to manage the pulse, GI motility, and discharge, the emission of the pancreas both endocrine and exocrine, glucose creation in the liver, and secretion. Acetylcholine (ACh) delivered by target cells, like smooth muscle cells, cardiovascular myocytes, and glandular cells, collaborates with muscarinic acetylcholine receptors (mAChRs) to carry out these roles [<xref ref-type="bibr" rid="cit19">19</xref>].</p><p>The vagus nerve additionally contains afferent neurons, comprising ~80% of the absolute neuronal count. The pseudo-unipolar neurons' present in the jugular ganglia and nodular are missing in the focal sensory system (CNS) as displayed in Figure 1 [<xref ref-type="bibr" rid="cit20">20</xref>].</p><fig id="fig-1"><caption><p>Figure 1. Electroacupuncture at the Hegu point activates the mental mAChR, which in turn activates the efferent vagus and splenic mitigating flagging, causing somatosensory initiation. Vagus nerve and splenic nerve flagging, which intervene via splenocytes' 7nAChR, regulate the progression of severe kidney injury and ameliorate the situation [20]. Image drawn from BioRender.</p><p>mAChR – muscarinic acetylcholine receptors; AchE – acetylcholinesterase; DMN – dorsal motor nucleus; NTS – nucleus tractus solitarius; PAMPs – pathogen-associated molecular patterns; TLR4 – toll-like receptor 4; ACh – acetylcholine; NE – norepinephrine; β2AR – beta-2-adrenergic receptor; T-ChAT – T-choline acetyltransferase cells; α7nAChR – alpha-7 nicotinic acetylcholine receptor; IL-1R – interleukin-1 receptor</p><p>Рисунок 1. Электроакупунктура в точке Хэгу активирует mAChR головного мозга, которые, в свою очередь, активируют эфферентные окончания блуждающего нерва и селезеночный нерв, смягчая их возбуждение и вызывая соматосенсорную инициацию. Воздействие блуждающего нерва и селезеночного нерва, которое осуществляется через 7nAChR на спленоцитах, регулирует прогрессирование тяжелого повреждения почек и улучшает состояние пациента [20]. Рисунок сделан в программе BioRender.</p><p>mAChR (англ. muscarinic acetylcholine receptors) – мускариновые ацетилхолиновые рецепторы; AchE (англ. acetylcholinesterase) – ацетилхолинэстераза; DMN (англ. dorsal motor nucleus) – дорсальное двигательное ядро; NTS (англ. nucleus tractus solitarius) – ядро солитарного тракта; PAMPs (англ. pathogen-associated molecular patterns) – патоген-ассоциированные молекулярные паттерны; TLR4 (англ. toll-like receptor 4) – толл-подобный рецептор 4; ACh (англ. acetylcholine) – ацетилхолин; NE (англ. norepinephrine) – норадреналин; β2AR (англ. beta-2-adrenergic receptor) – бета-2-адренорецептор; T-ChAT (англ. T-choline acetyltransferase cells) – холинацетилтрансфераза Т-клеток; α7nAChR (англ. alpha-7 nicotinic acetylcholine receptor) – альфа-7 никотиновый ацетилхолиновый рецептор; IL-1R (англ. interleukin-1 receptor) – рецептор интерлейкина-1</p></caption><graphic xlink:href="epilepsia-17-3-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/epilepsia/2025/3/Qupw5oXPWkwLPhiBNFj1Ya7zwEVomhEPduGO4NA3.jpeg</uri></graphic></fig></sec><sec><title>VAGUS NERVE AND THE CHOLINERGIC ANTI-INFLAMMATORY REFLEX: MECHANISMS AND MODELS / БЛУЖДАЮЩИЙ НЕРВ И ХОЛИНЕРГИЧЕСКИЙ ПРОТИВОВОСПАЛИТЕЛЬНЫЙ РЕФЛЕКС: МЕХАНИЗМЫ И МОДЕЛИ</title></sec><sec><title>Regulation of inflammation by vagus nerve / Регуляция воспаления блуждающим нервом</title><p>The tissue injury and disease are primarily safeguarded with the inception of aggravation. The various receptors like toll-like receptors (TLRs), NOD-like receptors (NLRs), and other sub-atomic sensors on resistant cells and their collaboration with microorganism are significant components for commencement of the immune rsponse during inflammation [<xref ref-type="bibr" rid="cit21">21</xref>][<xref ref-type="bibr" rid="cit22">22</xref>]. TNF, interleukin (IL)-1, IL-6, and IL-10 are among the cytokines that are produced as a result of this interaction's stimulation of nuclear factor-κB-mediated and other intracellular signalling pathways [<xref ref-type="bibr" rid="cit23">23</xref>][<xref ref-type="bibr" rid="cit24">24</xref>].</p><p>The synthesis of several pro- and anti-inflammatory cytokines, enhanced leucocyte recruitment in the inflamed area, angiogenesis, and the release of resolvins and other molecules, which can result in a rapid resolution, all work together to mediate a complex and balanced inflammatory process. An extensive progression was created by the identification of the efferent vagus nerve which, has a significant impact in the neuro-safe discourse with brain control of resistant capability and irritation [<xref ref-type="bibr" rid="cit25">25</xref>]. The role of in-rodents, regulated endotoxin lipopolysaccharide (LPS), vagotomy (a careful disturbance of the vagus nerve) is to expand the degrees of circling TNF, however a diminished degree of electrical feeling of the fringe vagus nerve in the neck. Alongside this, the focal atom set free from efferent vagus nerve axons diminishes the LPS-actuated TNF creation. This remarkable immunomodulatory action of the efferent vagus nerve was alluded to as a cholinergic mitigating pathway. It was likewise found that the receptor responsible for changing over cholinergic calming outpouring from the vagus nerve into a lessening in the age of proinflammatory cytokines is the nicotinic acetylcholine receptor (7nAChR), which is situated on macrophages and other safe cells [<xref ref-type="bibr" rid="cit12">12</xref>][<xref ref-type="bibr" rid="cit26">26</xref>].</p><p>The communication of the vagus nerve with the splenic nerve manages the aggravation reflex. It was fundamentally shown by addressing the concealment of splenic TNF and serum vagus nerve stimulation (VNS) in murine endotoxemia, which was repealed by splenic nerve crosscut. VNS additionally accelerates the arrival of ACh in the spleen. A small part of lymphocytes that have choline acetyltransferase (Talk), a pivotal protein in ACh fabricate, are a huge cell wellspring of this ACh. These lymphocytes with choline acetyltransferase (T-Visit) cells work with catecholaminergic actuation of ACh discharge heavily influenced by the vagus nerve as well as communicating-adrenergic receptors. As displayed in Figure 2, ACh likewise reacts with the alpha-7nAChR.</p><fig id="fig-2"><caption><p>Figure 2. A bioelectronic technique that targets the vagus nerves to reduce inflammation is shown schematically. Inflammation is decreased by acetylcholine, which is produced by splenic T-cells through an interaction with the splenic nerve and the vagus nerve. Image drawn from BioRender.</p><p>ACh – acetylcholine</p><p>Рисунок 2. Схема воздействия биоэлектронной технологии на блуждающий нерв для снижения воспаления. Воспаление уменьшается благодаря ацетилхолину, который вырабатывается Т-клетками селезенки при взаимодействии с селезеночным и блуждающим нервами. Рисунок сделан в программе BioRender.</p><p>ACh (англ. acetylcholine) – ацетилхолин</p></caption><graphic xlink:href="epilepsia-17-3-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/epilepsia/2025/3/o5nEgOHoQTuttPS8OEQxnWqYr3bo6VqpiFhDTaLL.jpeg</uri></graphic></fig></sec><sec><title>Regulating the inflammatory reflex and inflammation via brain signalling / Регулирование воспалительного рефлекса и воспаления посредством сигналов мозга</title><p>Guanylhydrazone’s (the vagus nerve's mitigating action) action is completely supported by the research involving the studies on anti-inflammatory chemical known as CNI-1493. The vagus nerves were found to be a significant brain-to-periphery transporter of CNI-1493 calming activities. CNI-1493 given in the cerebrum was found to diminish fringe cytokine levels. New brain restorative targets would be uncovered by an intensive planning of the mind networks that control the incendiary reflex and the vagus nerve's calming capability. In the future, bioelectronic medicine may be able to use these techniques to regulate brain networks to treat inflammatory diseases. Utilizing AI in obtaining the required role of inflammatory actions is achieving the in-sights in the field of advanced pharmaceutical technologies [<xref ref-type="bibr" rid="cit13">13</xref>][<xref ref-type="bibr" rid="cit27">27</xref>][<xref ref-type="bibr" rid="cit28">28</xref>].</p></sec><sec><title>Inflammatory VNS: animal models / VNS при воспалении: животные модели</title><p>Numerous studies employing VNS have revealed mechanistic information on the vagus nerve's anti-inflammatory effect and suggested new ways to treat inflammation. Concentrating on the cerebrum components in this field presents an entrancing region for impending exploration. Stimulation of vagus nerve has a potential to operate following functions: uncontrolled bleeding, murine endotoxemia, postoperative ileus, kidney ischemia-reperfusion injury, sepsis, haemorrhagic shock, and different problems. Aggravation and other obsessive parts of collagen-prompted joint pain in rodents are enormously diminished by once-everyday VNS managed through an embedded sleeve cathode for seven days [<xref ref-type="bibr" rid="cit29">29</xref>].</p><p>The seriousness of inflammatory bowel disease (IBD) (colitis) and colonic irritation are enormously decreased in rodents when a tantamount strategy – three hours of VNS excitement each day utilizing an embedded gadget – is utilized. Endotoxemia in mice resulted in a feeling of the cervical vagus nerve with a percutaneous needle terminal embedded under ultrasound direction, which fundamentally decreases fringe and CNS irritation (neuroinflammation). Aggravation control strategies utilizing painless VNS have additionally been examined. One of these procedures is vagus nerve stimulation in the auricular branch. The control of dying (discharge), body weight, and its suggestions for immunoregulation and incendiary administration have all been utilized to show the convenience of VNS [<xref ref-type="bibr" rid="cit30">30</xref>][<xref ref-type="bibr" rid="cit31">31</xref>].</p></sec><sec><title>VNS in human inflammatory diseases / VNS при воспалительных заболеваниях человека</title><p>Conditions including rheumatoid IBD, joint pain, and weight aggravation exist together with diminished vagus not entirely set in stone by pulse fluctuation examination. Results from bioelectronic VNS clinical examinations in patients with rheumatoid joint pain and IBD (Crohn's illness) have started to approve the translational relevance of preclinical discoveries. Crohn's sickness is a persistent provocative infection with restricted, costly, and related with broad unfavourable impact therapy choices [<xref ref-type="bibr" rid="cit32">32</xref>][<xref ref-type="bibr" rid="cit33">33</xref>]. In 5 out of 7 patients with dynamic sickness, VNS utilizing an embedded gadget decisively diminished the seriousness of the condition as proven by a diminished illness action score and better endoscopic outcomes [<xref ref-type="bibr" rid="cit27">27</xref>]. Patients with this condition who got bioelectronic VNS (up to 4 times each day) utilizing an embedded gadget experienced huge illness alleviation, as seen by perceptibly better infection scores, for as long as 84 days [<xref ref-type="bibr" rid="cit34">34</xref>]. Two patient partners – 7 patients in an early sickness stage showed no reaction to earlier methotrexate therapy and 10 people at a later illness stage who bombed treatments with a few biologics – answer well to this VNS treatment. Following VNS, clinical improvement in these rheumatoid joint pain patients happens simultaneously with drops in TNF and other cytokine levels [<xref ref-type="bibr" rid="cit35">35</xref>].</p></sec><sec><title>BIOELECTRONICS IN IMMUNITY / БИОЭЛЕКТРОНИКА В ИММУННОЙ СИСТЕМЕ</title></sec><sec><title>Organization of nervous system / Организация нервной системы</title><p>Nervous system consists of two parts, i.e. peripheral and CNS. The peripheral system has physical nerves that starts from the CNS, innervate skeletal muscles, and give voluntary control of actions. The autonomic nervous system has sympathetic, parasympathetic, and intestinal parts [<xref ref-type="bibr" rid="cit36">36</xref>]. The neurotransmitter signals are transferred through synapses between postganglionic strands and sensory neurons arranged in the spinal cord innervate veins, lymphoid tissue and organs, bone marrow, the lungs and aviation routes, gastrointestinal tract, liver, kidneys, and other instinctive organs. While ganglionic synaptic neurotransmission is cholinergic, postganglionic neurons discharge norepinephrine and, less significantly, different catecholamines (like adrenaline and dopamine), as well as neuropeptide Y [<xref ref-type="bibr" rid="cit28">28</xref>].</p></sec><sec><title>Regulation of neuronal reflex / Регуляция нейронального рефлекса</title><p>Neuroscientists in the mid-20th century worked for a very long time to thoroughly plan reflexes for regulating functional homeostasis in individuals. The reflex was named after Harvey Cushing, the pioneer behind current neurosurgery. He found it by setting an inflatable in a canine's head and looking for changes in pulse, pulse, and breath rate that happened subsequently [<xref ref-type="bibr" rid="cit37">37</xref>]. He isolated the vagus nerves to more readily comprehend the mind networks controlling these physiological responses, and he found that he could isolate the circulatory strain and pulse reactions that happened because of ascends in intracranial tension.</p><p>By the middle of the 20th century, these and other related tests led to the identifiable evidence of several reflexes, such as the vagus nerve and other nerves, as tools to regulate the homeostasis of almost every organ in the body, but not the safe framework. An example of a reflex that is both very simple and extremely complex, including several different types of neurones and central nervous system cooperation, is the axon reflex. Natural alterations are detected by tangible neurones, which then trigger an axon reflex response [<xref ref-type="bibr" rid="cit24">24</xref>][<xref ref-type="bibr" rid="cit38">38</xref>].</p></sec><sec><title>Signaling between the nervous and immune systems / Сигналы между нервной и иммунной системами</title><p>Niels Kaj Jerne quickly pointed towards the similarities for the anxious and invulnerable frameworks, as well as acknowledgment parts and the capacity to learn and shape recollections. One important source of indicators that affect the insusceptible framework's capacity and indicators from it is the sensory system [<xref ref-type="bibr" rid="cit39">39</xref>]. These associations are worked with by physical proximity and sharing sub-atomic sources of correspondence, including receptors and flagging particles. The skin and instinctive organs are innervated by afferent and efferent nerves, which are decisively positioned to screen harm and contamination destinations. Tactile neurons have been found to communicate particles that were beforehand just connected with resistant control, like example recognition receptors (like TLRs) and receptors for TNF, IL-1, and different cytokines [<xref ref-type="bibr" rid="cit40">40</xref>][<xref ref-type="bibr" rid="cit41">41</xref>]. Also, it had revealed that resistant cells express receptors that have generally been connected to fringe nerve guideline and brain transmission in the focal sensory system.</p></sec><sec><title>Sensory neurons and immune challenges / Сенсорные нейроны и иммунные проблемы</title><p>The body's all organs and tissues are innervated by afferent neurons, which go about as a vital channel for the CNS to get data about fringe changes in immunological homeostasis. Microbes and synthetically resistant substances animate tangible neurons that have focal associations with the cell bodies and spinal cord in the dorsal root ganglia [<xref ref-type="bibr" rid="cit42">42</xref>][<xref ref-type="bibr" rid="cit43">43</xref>]. These neurons along-with hand-off neurons and spinal interneurons transfer the reflexes to the mind inside the spinal cord. The essential subset of these neurons, known as nociceptors, is specialists in communicating various sorts of torment, which is likewise a pivotal part of irritation [<xref ref-type="bibr" rid="cit13">13</xref>].</p><p>On tactile neurons, the statement of different voltage-gated sodium channels as well as transient receptor potential particle channels intervenes in depolarization and explicit warm, mechanical, and substance aversions to harmful boosts [<xref ref-type="bibr" rid="cit13">13</xref>]. Through these receptors, cytokines like TNF, IL-1, IL-6, IL-17, prostaglandins, and different synthetic substances produced by adjacent invulnerable cells like neutrophils, pole cells, and macrophages associate with tangible neurons during disease, sensitivities, and tissue injury. At the point when there is a bacterial or viral contamination, cell harm, or an allergic response, vagal sensory neurons become dynamic [<xref ref-type="bibr" rid="cit44">44</xref>][<xref ref-type="bibr" rid="cit45">45</xref>].</p><p>TNF, IL-1, prostaglandins, serotonin, and different synthetic compounds created by resistant cells, like neutrophils, macrophages, and eosinophils, play a part in this enactment. When regulated to mice and rodents, lipopolysaccharide (LPS), IL-1 and TNF and contaminations such as Campylobacter jejuni, vagus nerve afferent transmission is activated. This flagging might be followed by the NTS to different brainstem and forebrain areas. These outcomes recommend that changed fringe immunological signs might influence afferent vagus nerve action in an unexpected way [<xref ref-type="bibr" rid="cit46">46</xref>][<xref ref-type="bibr" rid="cit47">47</xref>]. The various bioelectronic medicine approaches has been tabulated in Table 1.</p><table-wrap id="table-1"><caption><p>Table 1. Summary for bioelectronic medicine approaches</p><p>Таблица 1. Краткое описание подходов биоэлектронной медицины</p><p>Note. VNS – vagus nerve stimulation; TNF – tumor necrosis factor.</p><p>Примечание. VNS (англ. vagus nerve stimulation) – стимуляция блуждающего нерва; TNF (англ. tumor necrosis factor) – фактор некроза опухоли.</p></caption><table><tbody><tr><td>Condition / Состояние</td><td>Clinical result / Клииический результат</td><td>Mechanism / Механизм</td><td>Reference / Источник</td></tr><tr><td>Rheumatoid arthritis / Ревматоидный артрит</td><td>Decrease in severity of the disease using VNS, as determined by standardized clinical composite scores / Уменьшение тяжести заболевания при использовании VNS по оценке стандартизированных клинических комплексных показателей</td><td>The production of TNF and other pro-inflammatory cytokines are inhibited by the activation of neural circuitvia macrophages / Выработка TNF и других провоспалительных цитокинов подавляется при активации нейронных сетей через макрофаги</td><td>[48]</td></tr><tr><td>Crohn’s disease / Болезнь Крона</td><td>Among 7 participants 5 are evolved towards biological, clinical and endoscopic remission with a restored vagal tone after VNS / Из 7 участников у 5 наблюдается развитие биологической, клинической и эндоскопической ремиссии с восстановлением тонуса блуждающего нерва после VNS</td><td>– Afferents neurons activate the hypothalamic-pituitary-adrenal axis / Афферентные нейроны активируют гипоталамо-гипофизарно-надпочечниковую ось
– Efferent neurons activate the cholinergic anti-inflammatory pathway / Эфферентные нейроны активируют холинергический противовоспалительный путь</td><td>[49]</td></tr><tr><td>Paralysis / Паралич</td><td>C5–C6 to C7–T1 level motor impairment level improved allowing participants to hold and manipulate diverse size objects with different grips / Снижение двигательных нарушений на уровне от C5–C6 до C7–T1 позволило испытуемым удерживать и манипулировать предметами разных размеров с помощью разных захватов</td><td>Activation of muscles by neuromuscular stimulation is regulated by decoded intra-cortically recorded signals from the motor cortex / Активация мышц посредством нервно-мышечной стимуляции регулируется декодированными интракортикальными сигналами от двигательной коры</td><td>[50]</td></tr></tbody></table></table-wrap></sec><sec><title>Decoding hidden messages / Декодирование скрытых сообщений</title><p>Brain deciphering includes the area of signal handling and is a part of the search of man-made reasoning called AI to get familiar with the 'language of the sensory system'. This assists in diagnosing conditions such as Alzheimer’s, Parkinson’s, schizophrenia, and fanatical enthusiastic issue significantly quicker than conventional strategies [<xref ref-type="bibr" rid="cit51">51</xref>]. Essential examinations established the groundwork for the resulting brain unravelling explores associated with concentrating on the strategies to encode the data connected with tangible and engine capabilities. Further advancements in brain unravelling, and cerebrum PC interface (Brain-Computer Interface, BCI) innovation, prompted the examinations including human members existing with amyotrophic lateral sclerosis, stroke and also spinal rope injury [52–55].</p><p>In these underlying examinations, BCI and brain translating technology effectively permitted members to control the devices like PCs, mechanical arms, and an electric wheelchair through their solely with their eyes. Brain interpreting has basically been a field that has zeroed in on unravelling brain action connected with tangible, engine or even illness states inside the mind. In any case, the brain interpretation techniques that had been produced for the mind can be adjusted to the remainder of the sensory system later on. The single vagus nerve has roughly 100,000 filaments of which around 80% strands are afferent (tactile) filaments, conveying data from different organs and portions of the body to the cerebrum [56–59].</p></sec><sec><title>Treatment of paralysis via technology / Лечение паралича с помощью новых технологий</title><p>Previous BCI innovation permitted paralyzed patients to regulate PC cursors and wheel-chairs made ready for rebuilding development in their appendages. Early non-human examinations were briefly on incapacitated arm muscles which were initiated heavily influenced by a BCI. Later on, brain side-step’s innovation was created and shown in a first-barbaric review including a 23-year-old male quadriplegic member. A small terminal exhibit 96 cathodes with (4×4 mm across) was embedded in the brain cortex and using the brain interpretation technique; the review member had the option to rotate his paralyzed hand under the control of volitional. The member had the option to successfully recapture volitional finger and wrist developments by his own contemplations and to begin and shut down those developments when needed.</p></sec><sec><title>DEVICES AND MATERIALS FOR UNCOVERING NEW BIOLOGY / УСТРОЙСТВА И МАТЕРИАЛЫ ДЛЯ РАСКРЫТИЯ НОВОЙ БИОЛОГИИ</title><p>Due to improvements in micro-fabrication and novel materials, the bioelectronic interface has now been reduced from large scale connections capable of triggering whole muscles to gadgets that can link with specific cells and membrane proteins [<xref ref-type="bibr" rid="cit60">60</xref>]. Due to their vast variety of extent scales, these bioelectronic strategies are the finest technique to study and activate bioelectric circuits.</p></sec><sec><title>Biosensors / Биосенсоры</title><p>Biological markers, electric fields, and ionic concentrations can all be detected using bioelectronic sensors. Extensive categories of bioelectronic sensors were covered in past evaluations. Cell-sensors, or collections of cells, are the principal focus of both extracellular detection and intracellular recordings [<xref ref-type="bibr" rid="cit61">61</xref>][<xref ref-type="bibr" rid="cit62">62</xref>].</p></sec><sec><title>Extracellular neural activities / Внеклеточная нейронная активность</title><p>Biosensors like transistor-type provide signal magnification and extensive level multiplexing. A well-liked construction method for transistor-based biosensors (organic electrochemical transistor – OECT) is the organic electrochemical transistor. Poly (3, 4-ethylene di-oxythiophene): poly (styrene sulfonate) (PEDOT:PSS) was mixed with certain enzymes or antibodies to make a conventional OECT in order to identify compounds of interest [<xref ref-type="bibr" rid="cit60">60</xref>]. Due to the conducting channel's capacity to carry both electrons and ions, OECT has an intrinsic sensitivity to ionic classes in solution. In light of this, OECT behaves like a transducer between the two kinds of charge carriers. The health of the cells and how the barrier tissue responds to external substances may both be assessed using this transduction technique. three-dimensional tissue [<xref ref-type="bibr" rid="cit60">60</xref>][<xref ref-type="bibr" rid="cit63">63</xref>].</p></sec><sec><title>Intracellular recording / Внутриклеточная запись</title><p>The novel methodologies of microfabrication and nanomaterials permit the bioelectronic devices to mimic the receptor-mediated response of solitary cells to record membrane potential (voltage across the cell membrane – Vmem) [<xref ref-type="bibr" rid="cit64">64</xref>]. These signals are based on the advanced procedure of fix bracing. Most bioelectronic methods are spun around estimating spatiotemporal planning of Vmem of mechanized sensitive cells, like cardiomyocytes and neurons. Silicon nanowires with high perspective proportions and nanoscale distances across can interface the intracellular space and cross the cell layer with practically no mischief to the cell [<xref ref-type="bibr" rid="cit65">65</xref>][<xref ref-type="bibr" rid="cit66">66</xref>]. Vmem denotes the electrical potential difference between the outside and inside of a cell, typically produced by ion gradients (like Na+, K+, Cl–, Ca2+).
</p><p>In neurons, Vmem is critical for action potential generation and signal transmission. In non-excitable cells, Vmem also regulates processes such as cell proliferation, differentiation, migration, and tissue regeneration.</p><p>By changing the doping levels, a nanoscale field impact semiconductor might be made on a solitary nanowire due to the spatially controlled electrical signals of these nanowires. These crimped nanowires are framed to join to the tip of a nuclear power magnifying lens test and be embedded into the specific cell. Using silicon nanowire, enhances the potential cardiomyocyte activity inside the cell as compared to outside [<xref ref-type="bibr" rid="cit28">28</xref>][<xref ref-type="bibr" rid="cit67">67</xref>][<xref ref-type="bibr" rid="cit68">68</xref>].</p></sec><sec><title>Bio-actuators / Биоактуаторы</title><p>Galvani's initial work and contemporary clinical devices like pacemakers and brain inserts exhibit how bioelectric correspondence to cells arises over an electronic drive at the terminals that influences the activity capability of mechanized volatile cells [<xref ref-type="bibr" rid="cit69">69</xref>]. Here, we'll focus on bioelectronic device that can convey biophysical and synthetic signals straightforwardly to target specific cell processes.</p><p>The electrophoretic exchange of particles and minuscule atoms, like synapses, to change cell action is one of these signs. To move particles and little charged particles from a supply well into mass arrangement, natural electronic particle siphons made of PEDOT:PSS should undergo for ionically conductive poly-particle trade layer as well as with PEDOT:PSS anode. This makes different charged species be siphoned, including monovalent cations, gamma-aminobutyric acid, and acetylcholine. These natural particle siphons can ship various particles as well as charged atoms, yet the adequacy of their conveyance diminishes as the size of the particles gets bigger. It is possible to transport larger particles due to the directed penetrability of the dendrimer's ionic polymer, which permits increased particle transit [<xref ref-type="bibr" rid="cit70">70</xref>].</p></sec><sec><title>ROLE OF AI IN BIOELECTRONIC MEDICINE / РОЛЬ ИИ В БИОЭЛЕКТРОННОЙ МЕДИЦИНЕ</title><p>The emotionally supportive network should focus on a number of other extremely delicate issues, albeit an early determination would be extremely helpful, yet in addition on various other exceptionally delicate issues, for instance, a superior emergency, to comprehend which patients should be visible first. As a matter of fact, an early discovery of hostile instances, or in any event, featuring a few heinous acts that could prompt clinical mistakes, would be of extraordinary help.</p><p>The utilization of man-made perceptive in medication traces all the way back to the 1960s. A few endeavours to help clinical finding utilizing man-made reasoning were made then, at that point, for example, to recognize hazardous microscopic organisms and propose suitable treatment. Curiously, that framework had the option to propose great treatment with preferred execution over irresistible infection specialists. Following are the some key-points indicating role of AI in medicine:</p><p>– signal decoding – AI helps analyze and interpret complex neural signals;</p><p>– pattern recognition – AI identifies disease-specific electrical activity in the nervous system;</p><p>– therapy optimization – AI adjusts stimulation parameters in real time for better outcomes;</p><p>– personalized medicine – AI predicts patient response and enables tailored treatments;</p><p>– closed-loop systems – AI supports adaptive devices that respond instantly to physiological changes.</p><p>Pharmaceutical companies are now using AI to find more effective drug candidates and filter out those that could be harmful to humans before they go very far in the pipeline. Cutting out the weak drug candidates early on with AI saves millions of dollars and years of development [<xref ref-type="bibr" rid="cit71">71</xref>].</p></sec><sec><title>RECENT TRENDS AND DEVELOPMENTS / ПОСЛЕДНИЕ ТЕНДЕНЦИИ И РАЗРАБОТКИ</title><p>VNS holds the capability of giving productive method for treating an broad range of humanoid conditions, including IBD, joint pain (rheumatoid), ileus, abandoned dying, and the cutting-edge contagions – obesity and the firmly linked metabolic condition and type 2 diabetes. Translational improvements in bioelectronic medication followed by on-going preclinical and clinical examinations that are revealing novel insights into the capability of the vagus nerve in the control of irritation and restorative adequacy of the VNS, as explained previously.</p><p>Beyond vagus nerve modulation, bioelectronic medicine research also examines the regulatory mechanisms of other peripheral and central nervous system circuits and how to modify them therapeutically. Potential uses in a variety of illnesses, such as cancer, neurological disorders, diabetes, paralysis, cardiovascular diseases, and vision impairment, are being investigated in ongoing clinical studies. This field seeks to address disease progression and restore physiological equilibrium through precise modulation of bioelectrical signals. Furthermore, expanding bioelectronic interventions outside traditional neurological regulation presents both opportunities and concerns, as highlighted in contemporary discourse.</p><p>The essential focal point of bioelectronic medication is still brain mediation, albeit this field has drawn a lot of interest and consideration from both the general population and private areas, with GlaxoSmithKline (GSK) starting to lead the pack and putting more than $50 million USD in bioelectronic gadgets for therapeutic bids1. Run-of-the-mill electroceuticals connect with nerves and have gone through broad testing because of the great sensitivity of brain tissues and powerlessness to electrical excitement. It has various helpful purposes from vagus nerve triggers that treat inflammation and immune system diseases to instances of vision restoration with the cochlear implant.</p><p>Nonetheless, bioelectronics has been to a great extent ignored in the field of bioelectronic medication, notwithstanding being available in all cell types as electric fields, ionic flows, redox responses, and expected contrasts. Endogenous non-brain bioelectric motivations can make cells open and close ionic channels and actuate processes for quality record. These pathways can intercede the correspondence between safe cells and tissues and are participated in various cell processes, including movement, separation, and division [<xref ref-type="bibr" rid="cit51">51</xref>]. Medicines now accessible have harmfulness and aftereffects, including methotrexate and biologics including against TNF, hostile to IL-6 receptor, against CD20 antibodies, and white blood cell co-excitement inhibitor. Also, certain individuals don't profit from these treatments. The vagus nerve was invigorated for as long as 84 days by a bioelectronic embed in two gatherings of 17 patients, one of whom had bombed methotrexate treatment or treatment including at least two biologics, and the other of whom was in the early stages of the sickness and not answering methotrexate. The assembling of TNF is likewise diminished by this bioelectronic neuromodulation.</p></sec><sec><title>FUTURE PERSPECTIVES / ПЕРСПЕКТИВЫ</title><p>The majority of bioelectronic medical devices, such as deep brain stimulators, have a tendency to be quite intrusive. The nanoscale characteristics along with soft biocompatible materials reduce the invasiveness of the bioelectronic devices. Prof. Lieber's team at the University of Harvard confirmed the reduced invasiveness in bioelectronics injectables with some experiments like improving the flexible wearable electronics and tattoos by applying them directly to the patient’s skin, resulting in improved diagnostic capabilities. Future devices will deliver highly targeted stimulation to specific branches of the ANS, reducing side effects and improving therapeutic efficiency. Integration of biosensors with AI will allow real-time monitoring of physiological signals and adaptive control of stimulation. Devices will be tailored to individual patient profiles, enabling customized treatment plans for disorders such as hypertension, arrhythmias, and inflammatory diseases for personalized therapy.</p></sec><sec><title>CONCLUSION / ЗАКЛЮЧЕНИЕ</title><p>Focusing on the fiery reflex utilizing VNS can be a proficient new way to control variant aggravation in numerous illnesses. Worked on comprehension of the sensory system administrative capabilities and their changes in preclinical sickness models will keep on giving vital unthinking bits of knowledge to additional clinical preliminaries. Constant improvement of assembling methods and mechanical headways are driving a quick development in the bioelectronic medication field. In future, there could be critical headways in the field of bioelectronic medication, which coordinates and deciphers information about atomic standards of mind control and sickness causation into novel therapies for human illness based on neuromodulation of discrete neurocircuitries.</p><p>1. https://www.gsk.com/en-gb/media/press-releases/gsk-launches-50-million-venture-capital-fund-to-invest-in-pioneering-bioelectronic-medicines-and-technologies.
</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Löffler S., Melican K., Nilsson K.P.R., Richter-Dahlfors A. Organic bioelectronics in medicine. J Intern Med. 2017; 282 (1): 24–36. https://doi.org/10.1111/joim.12595.</mixed-citation><mixed-citation xml:lang="en">Löffler S., Melican K., Nilsson K.P.R., Richter-Dahlfors A. Organic bioelectronics in medicine. J Intern Med. 2017; 282 (1): 24–36. https://doi.org/10.1111/joim.12595.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J., Wang X., Vikash V., et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016: 2016: 4350965. https://doi.org/10.1155/2016/4350965.</mixed-citation><mixed-citation xml:lang="en">Zhang J., Wang X., Vikash V., et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016: 2016: 4350965. https://doi.org/10.1155/2016/4350965.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Drews J. Drug discovery: a historical perspective. Science. 2000; 287 (5460): 1960–4. https://doi.org/10.1126/science.287.5460.1960.</mixed-citation><mixed-citation xml:lang="en">Drews J. Drug discovery: a historical perspective. Science. 2000; 287 (5460): 1960–4. https://doi.org/10.1126/science.287.5460.1960.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">López-Muñoz F., Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009; 15 (14): 1563–86. https://doi.org/10.2174/138161209788168001.</mixed-citation><mixed-citation xml:lang="en">López-Muñoz F., Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009; 15 (14): 1563–86. https://doi.org/10.2174/138161209788168001.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fritsch G., Hitzig E. Electric excitability of the cerebrum (Über die elektrische Erregbarkeit des Grosshirns). Epilepsy Behav. 2009; 15 (2): 123–30. https://doi.org/10.1016/j.yebeh.2009.03.001.</mixed-citation><mixed-citation xml:lang="en">Fritsch G., Hitzig E. Electric excitability of the cerebrum (Über die elektrische Erregbarkeit des Grosshirns). Epilepsy Behav. 2009; 15 (2): 123–30. https://doi.org/10.1016/j.yebeh.2009.03.001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Penfield W., Boldrey E. Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain. 1937; 60 (4): 389–443.</mixed-citation><mixed-citation xml:lang="en">Penfield W., Boldrey E. Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain. 1937; 60 (4): 389–443.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dawson G.D. Investigations on a patient subject to myoclonic seizures after sensory stimulation. J Neurol Neurosurg Psychiatry. 1947; 10 (4): 141–62. https://doi.org/10.1136/jnnp.10.4.141.</mixed-citation><mixed-citation xml:lang="en">Dawson G.D. Investigations on a patient subject to myoclonic seizures after sensory stimulation. J Neurol Neurosurg Psychiatry. 1947; 10 (4): 141–62. https://doi.org/10.1136/jnnp.10.4.141.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Haas L. Hans Berger (1873–1941), Richard Caton (1842–1926), and electroencephalography. J Neurol Neurosurg Psychiatry. 2003; 74 (1): 9. https://doi.org/10.1136/jnnp.74.1.9.</mixed-citation><mixed-citation xml:lang="en">Haas L. Hans Berger (1873–1941), Richard Caton (1842–1926), and electroencephalography. J Neurol Neurosurg Psychiatry. 2003; 74 (1): 9. https://doi.org/10.1136/jnnp.74.1.9.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pearce J.M.S. Emil Heinrich Du Bois-Reymond (1818–96). J Neurol Neurosurg Psychiatry. 2001; 71 (5): 620. https://doi.org/10.1136/jnnp.71.5.620.</mixed-citation><mixed-citation xml:lang="en">Pearce J.M.S. Emil Heinrich Du Bois-Reymond (1818–96). J Neurol Neurosurg Psychiatry. 2001; 71 (5): 620. https://doi.org/10.1136/jnnp.71.5.620.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol. 1952; 117 (4): 500–44. https://doi.org/10.1113/jphysiol.1952.sp004764.</mixed-citation><mixed-citation xml:lang="en">Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol. 1952; 117 (4): 500–44. https://doi.org/10.1113/jphysiol.1952.sp004764.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlov V.A., Chavan S.S., Tracey K.J. Bioelectronic medicine: from preclinical studies on the inflammatory reflex to new approaches in disease diagnosis and treatment. Cold Spring Harb Perspect Med. 2020; 10 (3): a034140. https://doi.org/10.1101/cshperspect.a034140.</mixed-citation><mixed-citation xml:lang="en">Pavlov V.A., Chavan S.S., Tracey K.J. Bioelectronic medicine: from preclinical studies on the inflammatory reflex to new approaches in disease diagnosis and treatment. Cold Spring Harb Perspect Med. 2020; 10 (3): a034140. https://doi.org/10.1101/cshperspect.a034140.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Koopman F.A., Chavan S.S., Miljko S., et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci USA. 2016; 113 (29): 8284–9. https://doi.org/10.1073/pnas.1605635113.</mixed-citation><mixed-citation xml:lang="en">Koopman F.A., Chavan S.S., Miljko S., et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci USA. 2016; 113 (29): 8284–9. https://doi.org/10.1073/pnas.1605635113.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bonaz B., Sinniger V., Hoffmann D., et al. Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study. Neurogastroenterol Motil. 2016; 28 (6): 948–53. https://doi.org/10.1111/nmo.12792.</mixed-citation><mixed-citation xml:lang="en">Bonaz B., Sinniger V., Hoffmann D., et al. Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study. Neurogastroenterol Motil. 2016; 28 (6): 948–53. https://doi.org/10.1111/nmo.12792.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bouton C. Cracking the neural code, treating paralysis and the future of bioelectronic medicine. J Intern Med. 2017; 282 (1): 37–45. https://doi.org/10.1111/joim.12610.</mixed-citation><mixed-citation xml:lang="en">Bouton C. Cracking the neural code, treating paralysis and the future of bioelectronic medicine. J Intern Med. 2017; 282 (1): 37–45. https://doi.org/10.1111/joim.12610.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hochberg L.R., Serruya M.D., Friehs G.M., et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature. 2006; 442 (7099): 164–71. https://doi.org/10.1038/nature04970.</mixed-citation><mixed-citation xml:lang="en">Hochberg L.R., Serruya M.D., Friehs G.M., et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature. 2006; 442 (7099): 164–71. https://doi.org/10.1038/nature04970.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bouton C.E., Shaikhouni A., Annetta N.V., et al. Restoring cortical control of functional movement in a human with quadriplegia. Nature. 2016; 533 (7602): 247–50. https://doi.org/10.1038/nature17435.</mixed-citation><mixed-citation xml:lang="en">Bouton C.E., Shaikhouni A., Annetta N.V., et al. Restoring cortical control of functional movement in a human with quadriplegia. Nature. 2016; 533 (7602): 247–50. https://doi.org/10.1038/nature17435.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Klein E. Models of the patient-machine-clinician relationship in closed-loop machine neuromodulation. In: van Rysewyk S., Pontier M. (Eds) Machine medical ethics. Intelligent systems, control and automation: science and engineering, vol 74. Springer; 2014: 273–90. https://doi.org/10.1007/978-3-319-08108-3_17.</mixed-citation><mixed-citation xml:lang="en">Klein E. Models of the patient-machine-clinician relationship in closed-loop machine neuromodulation. In: van Rysewyk S., Pontier M. (Eds) Machine medical ethics. Intelligent systems, control and automation: science and engineering, vol 74. Springer; 2014: 273–90. https://doi.org/10.1007/978-3-319-08108-3_17.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tepper S.J., Rezai A., Narouze S., et al. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009; 49 (7): 983–9. https://doi.org/10.1111/j.1526-4610.2009.01451.x.</mixed-citation><mixed-citation xml:lang="en">Tepper S.J., Rezai A., Narouze S., et al. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache. 2009; 49 (7): 983–9. https://doi.org/10.1111/j.1526-4610.2009.01451.x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Deuschl G., Schade-Brittinger C., Krack P., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006; 355 (9): 896–908. https://doi.org/10.1056/NEJMoa060281.</mixed-citation><mixed-citation xml:lang="en">Deuschl G., Schade-Brittinger C., Krack P., et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006; 355 (9): 896–908. https://doi.org/10.1056/NEJMoa060281.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L., Wu Z., Zhou J., et al. Electroacupuncture ameliorates acute pancreatitis: a role for the vagus nerve-mediated cholinergic anti-inflammatory pathway. Front Mol Biosci. 2021: 8: 647647. https://doi.org/10.3389/fmolb.2021.647647.</mixed-citation><mixed-citation xml:lang="en">Zhang L., Wu Z., Zhou J., et al. Electroacupuncture ameliorates acute pancreatitis: a role for the vagus nerve-mediated cholinergic anti-inflammatory pathway. Front Mol Biosci. 2021: 8: 647647. https://doi.org/10.3389/fmolb.2021.647647.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sun F.T., Morrell M.J., Wharen R.E. Jr. Responsive cortical stimulation for the treatment of epilepsy. Neurotherapeutics. 2008; 5 (1): 68–74. https://doi.org/10.1016/j.nurt.2007.10.069.</mixed-citation><mixed-citation xml:lang="en">Sun F.T., Morrell M.J., Wharen R.E. Jr. Responsive cortical stimulation for the treatment of epilepsy. Neurotherapeutics. 2008; 5 (1): 68–74. https://doi.org/10.1016/j.nurt.2007.10.069.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Greenberg B.D., Malone D.A., Friehs G.M., et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006; 31 (11): 2384–93. https://doi.org/10.1038/sj.npp.1301165.</mixed-citation><mixed-citation xml:lang="en">Greenberg B.D., Malone D.A., Friehs G.M., et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006; 31 (11): 2384–93. https://doi.org/10.1038/sj.npp.1301165.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454 (7203): 428–35. https://doi.org/10.1038/nature07201.</mixed-citation><mixed-citation xml:lang="en">Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454 (7203): 428–35. https://doi.org/10.1038/nature07201.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chavan S.S., Tracey K.J. Essential neuroscience in immunology. J Immunol. 2017; 198 (9): 3389–97. https://doi.org/10.4049/jimmunol.1601613.</mixed-citation><mixed-citation xml:lang="en">Chavan S.S., Tracey K.J. Essential neuroscience in immunology. J Immunol. 2017; 198 (9): 3389–97. https://doi.org/10.4049/jimmunol.1601613.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Laxton A.W., Tang-Wai D.F., McAndrews M.P., et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol. 2010; 68 (4): 521–34. https://doi.org/10.1002/ana.22089.</mixed-citation><mixed-citation xml:lang="en">Laxton A.W., Tang-Wai D.F., McAndrews M.P., et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol. 2010; 68 (4): 521–34. https://doi.org/10.1002/ana.22089.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Tracey K.J. The inflammatory reflex. Nature. 2002; 420 (6917): 853–9. https://doi.org/10.1038/nature01321.</mixed-citation><mixed-citation xml:lang="en">Tracey K.J. The inflammatory reflex. Nature. 2002; 420 (6917): 853–9. https://doi.org/10.1038/nature01321.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000; 405 (6785): 458–62. https://doi.org/10.1038/35013070.</mixed-citation><mixed-citation xml:lang="en">Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000; 405 (6785): 458–62. https://doi.org/10.1038/35013070.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Rosas-Ballina M., Olofsson P.S., Ochani M., et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011; 334 (6052): 98–101. https://doi.org/10.1126/science.1209985.</mixed-citation><mixed-citation xml:lang="en">Rosas-Ballina M., Olofsson P.S., Ochani M., et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011; 334 (6052): 98–101. https://doi.org/10.1126/science.1209985.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Berthoud H.R. The vagus nerve, food intake and obesity. Regul Pept. 2008; 149 (1-3): 15–25. https://doi.org/10.1016/j.regpep.2007.08.024.</mixed-citation><mixed-citation xml:lang="en">Berthoud H.R. The vagus nerve, food intake and obesity. Regul Pept. 2008; 149 (1-3): 15–25. https://doi.org/10.1016/j.regpep.2007.08.024.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Masi E.B., Valdés-Ferrer S.I., Steinberg B.E. The vagus neurometabolic interface and clinical disease. Int J Obes. 2018; 42 (6): 1101–11. https://doi.org/10.1038/s41366-018-0086-1.</mixed-citation><mixed-citation xml:lang="en">Masi E.B., Valdés-Ferrer S.I., Steinberg B.E. The vagus neurometabolic interface and clinical disease. Int J Obes. 2018; 42 (6): 1101–11. https://doi.org/10.1038/s41366-018-0086-1.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Berthoud H.R., Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000; 85 (1-3): 1–17. https://doi.org/10.1016/S1566-0702(00)00215-0.</mixed-citation><mixed-citation xml:lang="en">Berthoud H.R., Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000; 85 (1-3): 1–17. https://doi.org/10.1016/S1566-0702(00)00215-0.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124 (4): 783–801. https://doi.org/10.1016/j.cell.2006.02.015.</mixed-citation><mixed-citation xml:lang="en">Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124 (4): 783–801. https://doi.org/10.1016/j.cell.2006.02.015.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Andersson U., Tracey K.J. Reflex principles of immunological homeostasis. Annu Rev Immunol. 2012; 30: 313–35. https://doi.org/10.1146/annurev-immunol-020711-075015.</mixed-citation><mixed-citation xml:lang="en">Andersson U., Tracey K.J. Reflex principles of immunological homeostasis. Annu Rev Immunol. 2012; 30: 313–35. https://doi.org/10.1146/annurev-immunol-020711-075015.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature. 2003; 421 (6921): 384–8. https://doi.org/10.1038/nature01339.</mixed-citation><mixed-citation xml:lang="en">Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature. 2003; 421 (6921): 384–8. https://doi.org/10.1038/nature01339.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tan C., Yan Q., Ma Y., et al. Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis. Front Neurol. 2022; 13: 1015175. https://doi.org/10.3389/fneur.2022.1015175.</mixed-citation><mixed-citation xml:lang="en">Tan C., Yan Q., Ma Y., et al. Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis. Front Neurol. 2022; 13: 1015175. https://doi.org/10.3389/fneur.2022.1015175.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Berthoud H.R., Powley T.L. Interaction between parasympathetic and sympathetic nerves in prevertebral ganglia: morphological evidence for vagal efferent innervation of ganglion cells in the rat. Microsc Res Tech. 1996; 35 (1): 80–6. https://doi.org/10.1002/(SICI)1097-0029(19960901)35:1&lt;80::AID-JEMT7&gt;3.0.CO;2-W.</mixed-citation><mixed-citation xml:lang="en">Berthoud H.R., Powley T.L. Interaction between parasympathetic and sympathetic nerves in prevertebral ganglia: morphological evidence for vagal efferent innervation of ganglion cells in the rat. Microsc Res Tech. 1996; 35 (1): 80–6. https://doi.org/10.1002/(SICI)1097-0029(19960901)35:1&lt;80::AID-JEMT7&gt;3.0.CO;2-W.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Bernik T.R., Friedman S.G., Ochani M., et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med. 2002; 195 (6): 781–8. https://doi.org/10.1084/jem.20011714.</mixed-citation><mixed-citation xml:lang="en">Bernik T.R., Friedman S.G., Ochani M., et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med. 2002; 195 (6): 781–8. https://doi.org/10.1084/jem.20011714.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Metz C.N., Pavlov V.A. Vagus nerve cholinergic circuitry to the liver and the gastrointestinal tract in the neuroimmune communicatome. Am J Physiol Gastrointest Liver Physiol. 2018; 315 (5): G651–8. https://doi.org/10.1152/ajpgi.00195.2018.</mixed-citation><mixed-citation xml:lang="en">Metz C.N., Pavlov V.A. Vagus nerve cholinergic circuitry to the liver and the gastrointestinal tract in the neuroimmune communicatome. Am J Physiol Gastrointest Liver Physiol. 2018; 315 (5): G651–8. https://doi.org/10.1152/ajpgi.00195.2018.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Levine Y.A., Koopman F.A., Faltys M., et al. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One. 2014; 9 (8): e104530. https://doi.org/10.1371/journal.pone.0104530.</mixed-citation><mixed-citation xml:lang="en">Levine Y.A., Koopman F.A., Faltys M., et al. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS One. 2014; 9 (8): e104530. https://doi.org/10.1371/journal.pone.0104530.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Meregnani J., Clarençon D., Vivier M., et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci. 2011; 160 (1-2): 82–9. https://doi.org/10.1016/j.autneu.2010.10.007.</mixed-citation><mixed-citation xml:lang="en">Meregnani J., Clarençon D., Vivier M., et al. Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Auton Neurosci. 2011; 160 (1-2): 82–9. https://doi.org/10.1016/j.autneu.2010.10.007.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Huffman W.J., Subramaniyan S., Rodriguiz R.M., et al. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice. Brain Stimul. 2019; 12 (1): 19–29. https://doi.org/10.1016/j.brs.2018.10.005.</mixed-citation><mixed-citation xml:lang="en">Huffman W.J., Subramaniyan S., Rodriguiz R.M., et al. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice. Brain Stimul. 2019; 12 (1): 19–29. https://doi.org/10.1016/j.brs.2018.10.005.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Czura C.J., Schultz A., Kaipel M., et al. Vagus nerve stimulation regulates hemostasis in swine. Shock. 2010; 33 (6): 608–13. https://doi.org/10.1097/SHK.0b013e3181cc0183.</mixed-citation><mixed-citation xml:lang="en">Czura C.J., Schultz A., Kaipel M., et al. Vagus nerve stimulation regulates hemostasis in swine. Shock. 2010; 33 (6): 608–13. https://doi.org/10.1097/SHK.0b013e3181cc0183.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lindgren S., Stewenius J., Sjölund K., et al. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol. 1993; 28 (7): 638–42. https://doi.org/10.3109/00365529309096103.</mixed-citation><mixed-citation xml:lang="en">Lindgren S., Stewenius J., Sjölund K., et al. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol. 1993; 28 (7): 638–42. https://doi.org/10.3109/00365529309096103.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlov V.A., Chavan S.S., Tracey K.J. Molecular and functional neuroscience in immunity. Annu Rev Immunol. 2018; 36: 783–812. https://doi.org/10.1146/annurev-immunol-042617-053158.</mixed-citation><mixed-citation xml:lang="en">Pavlov V.A., Chavan S.S., Tracey K.J. Molecular and functional neuroscience in immunity. Annu Rev Immunol. 2018; 36: 783–812. https://doi.org/10.1146/annurev-immunol-042617-053158.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000; 52 (4): 595–638.</mixed-citation><mixed-citation xml:lang="en">Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000; 52 (4): 595–638.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Jänig W. Sympathetic nervous system and inflammation: a conceptual view. Auton Neurosci. 2014; 182: 4–14. https://doi.org/10.1016/j.autneu.2014.01.004.</mixed-citation><mixed-citation xml:lang="en">Jänig W. Sympathetic nervous system and inflammation: a conceptual view. Auton Neurosci. 2014; 182: 4–14. https://doi.org/10.1016/j.autneu.2014.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Jänig W., Keast J.R., McLachlan E.M., et al. Renaming all spinal autonomic outflows as sympathetic is a mistake. Auton Neurosci. 2017; 206: 60–2. https://doi.org/10.1016/j.autneu.2017.04.003.</mixed-citation><mixed-citation xml:lang="en">Jänig W., Keast J.R., McLachlan E.M., et al. Renaming all spinal autonomic outflows as sympathetic is a mistake. Auton Neurosci. 2017; 206: 60–2. https://doi.org/10.1016/j.autneu.2017.04.003.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Schaible H.G. Nociceptive neurons detect cytokines in arthritis. Arthritis Res Ther. 2014; 16 (5): 470. https://doi.org/10.1186/s13075-014-0470-8.</mixed-citation><mixed-citation xml:lang="en">Schaible H.G. Nociceptive neurons detect cytokines in arthritis. Arthritis Res Ther. 2014; 16 (5): 470. https://doi.org/10.1186/s13075-014-0470-8.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Q., Liu H., Tang D., et al. Bioactuators based on stimulus-responsive hydrogels and their emerging biomedical applications. NPG Asia Materials. 2019; 11: 64. https://doi.org/10.1038/s41427-019-0165-3.</mixed-citation><mixed-citation xml:lang="en">Shi Q., Liu H., Tang D., et al. Bioactuators based on stimulus-responsive hydrogels and their emerging biomedical applications. NPG Asia Materials. 2019; 11: 64. https://doi.org/10.1038/s41427-019-0165-3.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Saboowala H. (Ed.) What is neural encoding and neural decoding? Neural decoding to decipher brain activity to treat paralysis, rheumatoid arthritis and epilepsy. 2019.</mixed-citation><mixed-citation xml:lang="en">Saboowala H. (Ed.) What is neural encoding and neural decoding? Neural decoding to decipher brain activity to treat paralysis, rheumatoid arthritis and epilepsy. 2019.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Yaprak M. The axon reflex. Neuroanatomy. 2008; 7: 17–9.</mixed-citation><mixed-citation xml:lang="en">Yaprak M. The axon reflex. Neuroanatomy. 2008; 7: 17–9.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes P. Asthma as an axon reflex. Lancet. 1986; 1 (8475): 242–5. https://doi.org/10.1016/s0140-6736(86)90777-4.</mixed-citation><mixed-citation xml:lang="en">Barnes P. Asthma as an axon reflex. Lancet. 1986; 1 (8475): 242–5. https://doi.org/10.1016/s0140-6736(86)90777-4.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Houghton B.L., Meendering J.R., Wong B.J., Minson C.T. Nitric oxide and noradrenaline contribute to the temperature threshold of the axon reflex response to gradual local heating in human skin. J Physiol. 2006; 572 (Pt 3): 811–20. https://doi.org/10.1113/jphysiol.2005.104067.</mixed-citation><mixed-citation xml:lang="en">Houghton B.L., Meendering J.R., Wong B.J., Minson C.T. Nitric oxide and noradrenaline contribute to the temperature threshold of the axon reflex response to gradual local heating in human skin. J Physiol. 2006; 572 (Pt 3): 811–20. https://doi.org/10.1113/jphysiol.2005.104067.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Charkoudian N., Wallin B.G. Sympathetic neural activity to the cardiovascular system: integrator of systemic physiology and interindividual characteristics. Compr Physiol. 2014; 4 (2): 825–50. https://doi.org/10.1002/cphy.c130038.</mixed-citation><mixed-citation xml:lang="en">Charkoudian N., Wallin B.G. Sympathetic neural activity to the cardiovascular system: integrator of systemic physiology and interindividual characteristics. Compr Physiol. 2014; 4 (2): 825–50. https://doi.org/10.1002/cphy.c130038.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Dampney R.A. Central neural control of the cardiovascular system: current perspectives. Adv Physiol Educ. 2016; 40 (3): 283–96. https://doi.org/10.1152/advan.00027.2016.</mixed-citation><mixed-citation xml:lang="en">Dampney R.A. Central neural control of the cardiovascular system: current perspectives. Adv Physiol Educ. 2016; 40 (3): 283–96. https://doi.org/10.1152/advan.00027.2016.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011; 12 (8): 453–66. https://doi.org/10.1038/nrn3071.</mixed-citation><mixed-citation xml:lang="en">Mayer E.A. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011; 12 (8): 453–66. https://doi.org/10.1038/nrn3071.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Travagli R.A., Hermann G.E., Browning K.N., Rogers R.C. Brainstem circuits regulating gastric function. Annu Rev Physiol. 2006; 68: 279–305. https://doi.org/10.1146/annurev.physiol.68.040504.094635.</mixed-citation><mixed-citation xml:lang="en">Travagli R.A., Hermann G.E., Browning K.N., Rogers R.C. Brainstem circuits regulating gastric function. Annu Rev Physiol. 2006; 68: 279–305. https://doi.org/10.1146/annurev.physiol.68.040504.094635.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Krohn K., Uibo R., Aavik E., et al. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet. 1992; 339 (8796): 770–3. https://doi.org/10.1016/0140-6736(92)91894-e.</mixed-citation><mixed-citation xml:lang="en">Krohn K., Uibo R., Aavik E., et al. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet. 1992; 339 (8796): 770–3. https://doi.org/10.1016/0140-6736(92)91894-e.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Hosoi T., Okuma Y., Matsuda T., Nomura Y. Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion. Auton Neurosci. 2005; 120 (1-2): 104–7. https://doi.org/10.1016/j.autneu.2004.11.012.</mixed-citation><mixed-citation xml:lang="en">Hosoi T., Okuma Y., Matsuda T., Nomura Y. Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion. Auton Neurosci. 2005; 120 (1-2): 104–7. https://doi.org/10.1016/j.autneu.2004.11.012.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Z.Z., Kim Y.H., Bang S., et al. Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade. Nat Med. 2015; 21 (11): 1326–31. https://doi.org/10.1038/nm.3978.</mixed-citation><mixed-citation xml:lang="en">Xu Z.Z., Kim Y.H., Bang S., et al. Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade. Nat Med. 2015; 21 (11): 1326–31. https://doi.org/10.1038/nm.3978.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Foley J.O., DuBois F.S. Quantitative studies of the vagus nerve in the cat: I. The ratio of sensory to motor fibers. J Compar Neurol. 1937; 67 (1): 49–67. https://doi.org/10.1002/cne.900670104.</mixed-citation><mixed-citation xml:lang="en">Foley J.O., DuBois F.S. Quantitative studies of the vagus nerve in the cat: I. The ratio of sensory to motor fibers. J Compar Neurol. 1937; 67 (1): 49–67. https://doi.org/10.1002/cne.900670104.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Ethier C., Oby E.R., Bauman M.J., Miller L.E. Restoration of grasp following paralysis through brain-controlled stimulation of muscles. Nature. 2012; 485 (7398): 368–71. https://doi.org/10.1038/nature10987.</mixed-citation><mixed-citation xml:lang="en">Ethier C., Oby E.R., Bauman M.J., Miller L.E. Restoration of grasp following paralysis through brain-controlled stimulation of muscles. Nature. 2012; 485 (7398): 368–71. https://doi.org/10.1038/nature10987.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Park C.K., Xu Z.Z., Berta T., et al. Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron. 2014; 82 (1): 47–54. https://doi.org/10.1016/j.neuron.2014.02.011.</mixed-citation><mixed-citation xml:lang="en">Park C.K., Xu Z.Z., Berta T., et al. Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron. 2014; 82 (1): 47–54. https://doi.org/10.1016/j.neuron.2014.02.011.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Steinberg B.E., Silverman H.A., Robbiati S., et al. Cytokine-specific neurograms in the sensory vagus nerve. Bioelectron Med. 2016; 3: 7–17.</mixed-citation><mixed-citation xml:lang="en">Steinberg B.E., Silverman H.A., Robbiati S., et al. Cytokine-specific neurograms in the sensory vagus nerve. Bioelectron Med. 2016; 3: 7–17.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Kawashima K., Fujii T., Moriwaki Y., Misawa H. Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sci. 2012; 91 (21–22): 1027–32. https://doi.org/10.1016/j.lfs.2012.05.006.</mixed-citation><mixed-citation xml:lang="en">Kawashima K., Fujii T., Moriwaki Y., Misawa H. Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function. Life Sci. 2012; 91 (21–22): 1027–32. https://doi.org/10.1016/j.lfs.2012.05.006.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Kawashima K., Fujii T., Moriwaki Y., et al. Non-neuronal cholinergic system in regulation of immune function with a focus on α7nAChRs. Int Immunopharmacol. 2015; 29 (1): 127–34. https://doi.org/10.1016/j.intimp.2015.04.015.</mixed-citation><mixed-citation xml:lang="en">Kawashima K., Fujii T., Moriwaki Y., et al. Non-neuronal cholinergic system in regulation of immune function with a focus on α7nAChRs. Int Immunopharmacol. 2015; 29 (1): 127–34. https://doi.org/10.1016/j.intimp.2015.04.015.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Talbot S., Foster S.L., Woolf C.J. Neuroimmunity: physiology and pathology. Annu Rev Immunol. 2016; 34: 421–47. https://doi.org/10.1146/annurev-immunol-041015-055340.</mixed-citation><mixed-citation xml:lang="en">Talbot S., Foster S.L., Woolf C.J. Neuroimmunity: physiology and pathology. Annu Rev Immunol. 2016; 34: 421–47. https://doi.org/10.1146/annurev-immunol-041015-055340.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Pinho-Ribeiro F.A., Verri W.A. Jr., Chiu I.M. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017; 38 (1): 5–19. https://doi.org/10.1016/j.it.2016.10.001.</mixed-citation><mixed-citation xml:lang="en">Pinho-Ribeiro F.A., Verri W.A. Jr., Chiu I.M. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017; 38 (1): 5–19. https://doi.org/10.1016/j.it.2016.10.001.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Lai N.Y., Mills K., Chiu I.M. Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence. J Intern Med. 2017; 282 (1): 5–23. https://doi.org/10.1111/joim.12591.</mixed-citation><mixed-citation xml:lang="en">Lai N.Y., Mills K., Chiu I.M. Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence. J Intern Med. 2017; 282 (1): 5–23. https://doi.org/10.1111/joim.12591.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Julius D. TRP channels and pain. Annu Rev Cell Dev Biol. 2013; 29: 355–84. https://doi.org/10.1146/annurev-cellbio-101011-155833.</mixed-citation><mixed-citation xml:lang="en">Julius D. TRP channels and pain. Annu Rev Cell Dev Biol. 2013; 29: 355–84. https://doi.org/10.1146/annurev-cellbio-101011-155833.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Bollella P., Fusco G., Tortolini C., et al. Beyond graphene: electrochemical sensors and biosensors for biomarkers detection. Biosens Bioelectron. 2017; 89 (Pt 1): 152–66. https://doi.org/10.1016/j.bios.2016.03.068.</mixed-citation><mixed-citation xml:lang="en">Bollella P., Fusco G., Tortolini C., et al. Beyond graphene: electrochemical sensors and biosensors for biomarkers detection. Biosens Bioelectron. 2017; 89 (Pt 1): 152–66. https://doi.org/10.1016/j.bios.2016.03.068.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
